Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
Nature Cell Biology
|
February 6, 2007
Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression
Melanie Wissmann, Na Yin, Judith M Müller, et al.
Molecular Oncology
|
October 4, 2014
SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancer
Kerstin Rönsch, Sabine Jägle, Katja Rose, et al.
Cancer Research
|
December 6, 2006
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence
Philip Kahl, Lucia Gullotti, Lukas Carl Heukamp, et al.
Nature Cell Biology
|
December 11, 2007
Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation
Eric Metzger, Na Yin, Melanie Wissmann, et al.
Cells
|
February 25, 2023
Overexpression of KMT9α Is Associated with Aggressive Basal-like Muscle-Invasive Bladder Cancer
Florestan J Koll, Eric Metzger, Jana Hamann, et al.
Nature Communications
|
January 23, 2014
Lysine-specific demethylase 1 regulates differentiation onset and migration of trophoblast stem cells
Dongmei Zhu, Stefanie Hölz, Eric Metzger, et al.
Materials Today. Bio
|
April 10, 2025
Modeling a mesenchymal cell state by bioprinting for the molecular analysis of dormancy in melanoma
Sonja K Schmidt, Stefan Fischer, Zubeir El Ahmad, et al.
Journal of Medicinal Chemistry
|
September 7, 2013
Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity
Martin L Schmitt, Alexander-Thomas Hauser, Luca Carlino, et al.
Elife
|
February 3, 2016
Maternal LSD1/KDM1A is an essential regulator of chromatin and transcription landscapes during zygotic genome activation
Katia Ancelin, Laurène Syx, Maud Borensztein, et al.
International Journal of Cancer
|
March 27, 2012
Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor
Dominica Willmann, Soyoung Lim, Stefan Wetzel, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
Nature Cell Biology
|
February 6, 2007
Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression
Melanie Wissmann, Na Yin, Judith M Müller, et al.
Molecular Oncology
|
October 4, 2014
SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancer
Kerstin Rönsch, Sabine Jägle, Katja Rose, et al.
Cancer Research
|
December 6, 2006
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence
Philip Kahl, Lucia Gullotti, Lukas Carl Heukamp, et al.
Nature Cell Biology
|
December 11, 2007
Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation
Eric Metzger, Na Yin, Melanie Wissmann, et al.
Cells
|
February 25, 2023
Overexpression of KMT9α Is Associated with Aggressive Basal-like Muscle-Invasive Bladder Cancer
Florestan J Koll, Eric Metzger, Jana Hamann, et al.
Nature Communications
|
January 23, 2014
Lysine-specific demethylase 1 regulates differentiation onset and migration of trophoblast stem cells
Dongmei Zhu, Stefanie Hölz, Eric Metzger, et al.
Materials Today. Bio
|
April 10, 2025
Modeling a mesenchymal cell state by bioprinting for the molecular analysis of dormancy in melanoma
Sonja K Schmidt, Stefan Fischer, Zubeir El Ahmad, et al.
Journal of Medicinal Chemistry
|
September 7, 2013
Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity
Martin L Schmitt, Alexander-Thomas Hauser, Luca Carlino, et al.
Elife
|
February 3, 2016
Maternal LSD1/KDM1A is an essential regulator of chromatin and transcription landscapes during zygotic genome activation
Katia Ancelin, Laurène Syx, Maud Borensztein, et al.
International Journal of Cancer
|
March 27, 2012
Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor
Dominica Willmann, Soyoung Lim, Stefan Wetzel, et al.
Page
of 6